【医汇集团(08161.HK)拟1440万港元出售恒泉全部已发行股本】医汇集团(08161.HK)发布公告,于2025年1月9日,卖方(公司的全资附属公司)与买方赵创波订立买卖协议,卖方有条件同意出售,而买方有条件同意收购销售股份(相当于目标公司全部已发行股本),代价为1440万港元,并受买卖协议的条款及条件所限。

金融界
Jan 10, 2025
医汇集团(08161.HK)发布公告,于2025年1月9日,卖方(公司的全资附属公司)与买方赵创波订立买卖协议,卖方有条件同意出售,而买方有条件同意收购销售股份(相当于目标公司全部已发行股本),代价为1440万港元,并受买卖协议的条款及条件所限。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10